LGND
Ligand Pharmaceuticals Inc
Price:  
120.36 
USD
Volume:  
113,046.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND WACC - Weighted Average Cost of Capital

The WACC of Ligand Pharmaceuticals Inc (LGND) is 7.7%.

The Cost of Equity of Ligand Pharmaceuticals Inc (LGND) is 7.75%.
The Cost of Debt of Ligand Pharmaceuticals Inc (LGND) is 5.50%.

Range Selected
Cost of equity 6.80% - 8.70% 7.75%
Tax rate 20.90% - 41.60% 31.25%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.8% - 8.7% 7.7%
WACC

LGND WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 8.70%
Tax rate 20.90% 41.60%
Debt/Equity ratio 0 0
Cost of debt 4.00% 7.00%
After-tax WACC 6.8% 8.7%
Selected WACC 7.7%